{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T23:09:46Z","timestamp":1777936186695,"version":"3.51.4"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2026,5,1]]},"DOI":"10.2169\/internalmedicine.6089-25","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T22:08:27Z","timestamp":1759356507000},"page":"1239-1244","source":"Crossref","is-referenced-by-count":0,"title":["Refractory SIAD Triggered by Herpes Zoster Ophthalmicus: Impact of Postherpetic Neuralgia on Hyponatremia Duration and the Role of Tolvaptan"],"prefix":"10.2169","volume":"65","author":[{"given":"So","family":"Kawasaki","sequence":"first","affiliation":[{"name":"Department of Nephrology, Nishiyodo Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Taniguchi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Clinical Immunology, Graduate School of Medicine, Kyoto University, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Anderson RJ. Hospital-associated hyponatremia. Kidney Int 29: 1237-47, 1986.","DOI":"10.1038\/ki.1986.134"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Adrogu\u00e9 HJ, Madias NE. The syndrome of inappropriate antidiuresis. N Engl J Med 389: 1499-1509, 2023.","DOI":"10.1056\/NEJMcp2210411"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Tzoulis P, Kaltsas G, Baldeweg SE, Bouloux PM, Grossman AB. Tolvaptan for the treatment of the syndrome of inappropriate antidiuresis (SIAD). Ther Adv Endocrinol Metab 14: 20420188231173327, 2023.","DOI":"10.1177\/20420188231173327"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Liesegang TJ. Herpes zoster ophthalmicus natural history, risk factors, clinical presentation, and morbidity. Ophthalmology 115 (Suppl): S3-S12, 2008.","DOI":"10.1016\/j.ophtha.2007.10.009"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Dworkin RH, Gnann JW Jr, Oaklander AL, Raja SN, Schmader KE, Whitley RJ. Diagnosis and assessment of pain associated with herpes zoster and postherpetic neuralgia. J Pain 9 (Suppl 1): S37-44, 2008.","DOI":"10.1016\/j.jpain.2007.10.008"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Wang CC, Shiang JC, Chen JT, Lin SH. Syndrome of inappropriate secretion of antidiuretic hormone associated with localized herpes zoster ophthalmicus. J Gen Intern Med 26: 216-220, 2011.","DOI":"10.1007\/s11606-010-1517-4"},{"key":"7","doi-asserted-by":"publisher","unstructured":"7. Adrogu\u00e9 HJ, Tucker BM, Madias NE. Diagnosis and management of hyponatremia: a review. JAMA 328: 280-291, 2022.","DOI":"10.1001\/jama.2022.11176"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Schrier RW, Gross P, Gheorghiade M, et al.; the SALT Investigators. Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia. N Engl J Med 355: 2099-2112, 2006.","DOI":"10.1056\/NEJMoa065181"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Lewellyn D, Nuamek T, Ostarijas E, et al. Low-dose tolvaptan for the treatment of syndrome of inappropriate antidiuretic hormone-associated hyponatremia: a systematic review, meta-analysis, and meta-regression analysis of clinical effectiveness and safety. Endocr Pract 31: 956-964, 2025.","DOI":"10.1016\/j.eprac.2025.04.012"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Men\u00e9trey D, Basbaum AI. Spinal and trigeminal projections to the nucleus of the solitary tract: a possible substrate for somatovisceral and viscerovisceral reflex activation. J Comp Neurol 255: 439-450, 1987.","DOI":"10.1002\/cne.902550310"},{"key":"11","unstructured":"11. Majdak MO, Goraca A, G\u0142abi\u0144ski A, Traczyk WZ. Vasopressin release into the 3rd cerebral ventricle and into the blood after sciatic and trigeminal nerve stimulation. J Physiol Pharmacol  45: 309-317, 1994."},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Baba K, Kawasaki M, Nishimura H, et al. Upregulation of the hypothalamo-neurohypophysial system and activation of vasopressin neurones attenuates hyperalgesia in a neuropathic pain model rat. Sci Rep 12: 13046, 2022.","DOI":"10.1038\/s41598-022-17477-5"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Calenda E, Muraine M, Dessole E. Is the syndrome of inappropriate secretion of antidiuretic hormone responsible for hyponatremia in a patient with herpes varicella zoster virus? South Med J 89: 1224, 1996.","DOI":"10.1097\/00007611-199612000-00022"},{"key":"14","unstructured":"14. Han MK, Lee JG, Han HJ, Lee KH, Han SH, Lee SS. Syndrome of inappropriate secretion of antidiuretic hormone (SIADH) associated with herpes zoster ophthalmicus. J Korean Neurol Ass 13: 298-301, 1996."},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Dhawan SS. Herpes zoster ophthalmicus and syndrome of inappropriate antidiuretic hormone secretion. Am J Med Sci 333: 56-57, 2007.","DOI":"10.1097\/00000441-200701000-00008"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Kucukardali Y, Solmazgul E, Terekeci H, Oncul O, Turhan V. Herpes zoster ophthalmicus and syndrome of inappropriate antidiuretic hormone secretion. Intern Med 47: 463-465, 2008.","DOI":"10.2169\/internalmedicine.47.0629"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Shima T, Yamashita K, Furuta K, et al. Right-sided herpes zoster ophthalmicus complicated by bilateral third, fourth, and sixth cranial nerve palsies and syndrome of inappropriate antidiuretic hormone secretion. Intern Med 63: 2673-2677, 2024.","DOI":"10.2169\/internalmedicine.2878-23"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Yamagata S, Kageyama K, Yanagimachi M, Murakami H, Daimon M. Simultaneous occurrence of hyponatremia and hypokalemia in a patient with herpes zoster: a case report with a review of the literature. Intern Med 64: 261-266, 2025.","DOI":"10.2169\/internalmedicine.3795-24"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Arani RB, Soong SJ, Weiss HL, et al. Phase specific analysis of herpes zoster associated pain data: a new statistical approach. Stat Med 20: 2429-2439, 2001.","DOI":"10.1002\/sim.851.abs"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Low PA, Dotson RM. Symptomatic treatment of painful neuropathy. JAMA 280: 1863-1864, 1998.","DOI":"10.1001\/jama.280.21.1863"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Arvin AM. Varicella-zoster virus. Clin Microbiol Rev 9: 361-381, 1996.","DOI":"10.1128\/CMR.9.3.361"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Johnson RW, Rice AS. Clinical practice. Postherpetic neuralgia. N Engl J Med 371: 1526-1533, 2014.","DOI":"10.1056\/NEJMcp1403062"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/9\/65_6089-25\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:22:17Z","timestamp":1777692137000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/65\/9\/65_6089-25\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":22,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6089-25","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,1]]},"article-number":"6089-25"}}